Pegylated interferon plus ribavirin versus non‐pegylated interferon plus ribavirin for chronic hepatitis C
Información
- DOI:
- https://doi.org/10.1002/14651858.CD005441.pub2Copiar DOI
- Base de datos:
-
- Cochrane Database of Systematic Reviews
- Versión publicada:
-
- 07 octubre 2009see what's new
- Tipo:
-
- Intervention
- Etapa:
-
- Protocol
- Grupo Editorial Cochrane:
-
Grupo Cochrane de Hepatobiliar
- Copyright:
-
- Copyright © 2010 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Cifras del artículo
Altmetric:
Citado por:
Autores
Contributions of authors
Tahany Awad drafted the protocol, will perform the literature search, will perform the data extraction, will assess the risk of bias in the included trials, will perform all statistical analyses that can be done in RevMan, will contribute to the interpretation of results, and will draft the review. Jesper Brok revised the protocol, will perform the data extraction, will asses the risk of bias in the included trials, will contribute to the interpretation of results, and will revise the review. Kristian Thorlund revised the protocol, will assess the risk of bias associated with incomplete outcome data, will perform all statistical analyses that could not be done in RevMan including TSA, will contribute to the interpretation of results, and will revise the review. Goran Hauser will perform the data extraction and asses the risk of bias in the included trials. Davor Stimac will contribute to the interpretation of results and will revise the review. Mahasen Mabrouk, Christian Gluud, and Lise Lotte Gluud revised the protocol, will act as an arbitrator for disagreements in data extraction and the bias risk assessment, will contribute to the interpretation of results, and will revise the review.
Sources of support
Internal sources
-
Copenhagen Trial Unit, Centre for Clinical Intervention Research, H:S Rigshospitalet, Denmark.
External sources
-
No sources of support supplied
Declarations of interest
None known.
Acknowledgements
Special thanks to Dimitrinka Nikolova for her advice, encouragement, and support during the preparation of this protocol. Thanks to Sarah Klingenberg for advising on search strategy. Thanks to Marija Simin for drafting the previous version of the protocol (Simin 2005).
Peer Reviewers: David Wong, USA; Christian Trepo, France; Zahari Krastev, Bulgaria; Anna Fracanzani, Italy.
Contact Editors: Ronald L Koretz, USA; Bodil Als‐Nielsen, Denmark.
Version history
Published | Title | Stage | Authors | Version |
2014 Feb 28 | Peginterferon plus ribavirin versus interferon plus ribavirin for chronic hepatitis C | Review | Goran Hauser, Tahany Awad, Jesper Brok, Kristian Thorlund, Davor Štimac, Mahasen Mabrouk, Christian Gluud, Lise Lotte Gluud | |
2009 Oct 07 | Pegylated interferon plus ribavirin versus non‐pegylated interferon plus ribavirin for chronic hepatitis C | Protocol | Tahany Awad, Jesper Brok, Kristian Thorlund, Goran Hauser, Davor Stimac, Mahasen Mabrouk, Christian Gluud, Lise Lotte Gluud | |
2009 Jul 08 | Pegylated interferon plus ribavirin versus non‐pegylated interferon plus ribavirin for chronic hepatitis C | Protocol | Marija Simin, Jesper Brok, Davor Stimac, Christian Gluud, Lise Lotte Gluud | |
Keywords
MeSH
Medical Subject Headings (MeSH) Keywords
- Amantadine [therapeutic use];
- Antiviral Agents [*therapeutic use];
- Drug Therapy, Combination [methods];
- Hepatitis C, Chronic [*drug therapy, mortality];
- Interferon alpha-2;
- Interferon-alpha [*therapeutic use];
- Interferons [*therapeutic use];
- Polyethylene Glycols [*therapeutic use];
- Randomized Controlled Trials as Topic;
- Recombinant Proteins [therapeutic use];
- Ribavirin [*therapeutic use];
Medical Subject Headings Check Words
Humans;